Cancer outcomes measurement: Through the lens of the Medical Outcomes Trust framework

Quality of Life Research

Volumn 16, Issue 1, 2007, Pages 143-164

  Lipscomb, Joseph ^a   Snyder, Claire F ^b   Gotay, Carolyn C ^c  

^a EMORY UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Health related quality of life; Oncology; Outcomes research; Patient reported outcomes

Indexed keywords

ADAPTATION; ARTICLE; BREAST CANCER; CANCER; CANCER LOCALIZATION; CANCER OUTCOMES MEASUREMENT WORKING GROUP; CANCER RESEARCH; COLORECTAL CANCER; CONCEPTUAL FRAMEWORK; CULTURAL ANTHROPOLOGY; DECISION MAKING; DIAGNOSIS RELATED GROUP; FEASIBILITY STUDY; HUMAN; INSTRUMENTATION; LANGUAGE; LUNG CANCER; METHODOLOGY; MODEL; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; PSYCHOMETRY; QUALITY OF LIFE; RATING SCALE; RELIABILITY; RESEARCH; RESPONSIBILITY; THEORY; VALIDITY; WORK;

ENDPOINT DETERMINATION; HEALTH STATUS INDICATORS; HUMANS; NEOPLASMS; PATIENT PARTICIPATION; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 33845997742     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-006-9116-x     Document Type: Article

References (51)

1. U.S. National Cancer Institute. Cancer Outcomes Measurement Working Group. Retrieved February 7, 2006, from http://www.outcomes.cancer.gov/methods/ measures/comwg/.
2. Scientific Advisory Committee of the Medical Outcomes Trust (Aaronson N, Alonso J, Burnam A, Lohr KN, Patrick DL, Perrin E, Stein REK). Assessing health status and quality-of-life instruments: Attributes and review criteria. Qual Life Res 2002; 11: 193-205.
3. Lipscomb J, Gotay CC, Snyder C. Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005.
4. Lipscomb J, Donaldson MS, Arora NK, et al. Cancer outcomes research. J Natl Cancer Inst Monogr 2004; 33: 178-197.
5. Gotay CC, Lipscomb J, Snyder CF. Reflections on findings of the Cancer Outcomes Measurement Working Group: Moving to the next phase. J Natl Cancer Inst 2005; 97: 1568-1574.
6. Erickson P. Assessing health status and quality of life of cancer patients: The use of general instruments. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 31-68.
7. Ganz PA, Goodwin PJ. Quality of life in breast cancer - what have we learned and where do we go from here? In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 93-125.
8. Litwin MS, Talcott JA. Measuring quality of life in prostate cancer: Progress and challenges. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 126-159.
9. Earle CC, Weeks JC. The science of quality-of-life measurement in lung cancer. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 160-177.
10. Moinpour CM, Provenzale D. Treatment for colorectal cancer: Impact on health-related quality of life. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 178-200.
11. Zebrack B, Cella D. Evaluating quality of life in cancer survivors. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 241-263.
12. Ferrell BR. Assessing health-related quality of life at end of life. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 264-285.
13. Snyder C. Assessing the subjective impact of caregiving on informal caregivers of cancer patients. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 329-345.
14. Ferrans CE. Definitions and conceptual models of quality of life. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 14-30.
15. Kemmler G, Holzner B, Kopp M, et al. Comparison of two quality-of-life instruments for cancer patients: The Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C30. J Clin Oncol 1999; 17: 2932-2940.
16. Aaronson NK. Cross-cultural use of health-related quality of life assessments in clinical oncology. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 406-424.
17. Fairclough DL. Practical considerations in outcomes assessment for clinical trials. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 346-361.
18. Mandelblatt JS, Selby JV. Short-term outcomes of chemoprevention, genetic susceptibility testing, and screening interventions: What are they? How are they measured? When should they be measured? In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 216-240.
19. Feeny DH. The roles for preference-based measures in support of cancer research and policy. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 69-92.
20. Reise SP. Item response theory and its applications for cancer outcomes measurement. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 425-444.
21. Hambleton RK. Applications of item response theory to improve outcomes measurement: Developing item banks, linking instruments, and computer-adaptive testing. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 445-464.
22. Williams JE. Patient advocate perspective on health-related quality of life issues with prostate cancer survivors. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 286-289.
23. Barry MJ, Dancey JE. Instruments to measure the specific health impact of surgery, radiation, and chemotherapy on cancer patients. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 201-215.
24. Fayers PM, Machin D. Quality of Life: Assessment, Analysis, Interpretation. Chichester, England: John Wiley & Sons, 2002.
25. Reise SP, Henson JM. A discussion of modern versus traditional psychometrics as applied to personality assessment scales. J Personal Assess 2003; 81(2): 93-103.
26. McHorney CA, Haley SM, Ware JE Jr.. Evaluation of the MOS SF-36 Physical Functioning Scale (PF-10): II. Comparison of relative precision using Likert and Rasch scoring methods.. J Clin Epidemiol 1997; 50(4): 451-467.
27. Kosinski M, Bjorner JB, Ware JE Jr, et al. The responsiveness of headache impact scales scored using 'classical' and 'modern' psychometric methods: A re-analysis of three clinical trials. Qual Life Res 2003; 12: 903-912.
28. Sloan JA, Cella D, Frost MH, et al. Assessing clinical significance in measuring oncology patient quality of life: Introduction to the symposium, content overview, and definition of terms. Mayo Clin Proc 2002; 77: 367-370.
29. Osoba D. The clinical value and meaning of health-related quality-of-life outcomes in oncology. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 386-405.
30. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
31. Schwartz CE, Sprangers MAG. Adaptation to Changing Health: Response Shift in Quality-of-Life Research. Washington, DC: American Psychological Association, 2000.
32. Sprangers MAG, Schwartz CE. Integrating response shift into quality-of-life research: A theoretical model. Soc Sci Med 1999; 48: 1507-1515.
33. Gotay CC, Lipscomb J, Snyder C. Reflections on COMWG findings and moving to the next phase. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 568-583.
34. National Institutes of Health. Patient-Reported Outcomes Measurement Information System: Dynamic Tools to Measure Health Outcomes from the Patient Perspective. Retrieved February 10, 2006, from http://www.nihPROMIS.org/.
35. McHorney CA, Cook K. The ten D's of health outcomes measurement for the 21st century. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 590-609.
36. Gotay CC, Lipscomb J. Data for cancer outcomes research: Identifying and strengthening the empirical base. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 522-549.
37. Johnson JR, Williams G, Pazdur R. End points and United States Food and Drug Administration approval of oncology drugs. Journal of Clinical Oncology 2003; 21: 1404-1411.
38. U.S. Food and Drug Administration. Guidance for Industry - Patient-Reported Outcome Measures: Use in Medical Product Development to Support Labeling Claims (DRAFT). Available at http://www.fda.gov/cber/gdlns/prolbl.pdf. Accessed March 20, 2006.
39. Wilson M. Subscales and summary scales: Issues in health-related outcomes. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 465-479.
40. O'Brien BJ. Cost-effectiveness analysis in cancer: Toward an iterative framework for integration of evidence from trials and models. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 503-521.
41. Hornbrook MC. On the definition and measurement of the economic burden of cancer. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 480-502.
42. Sloan JA. Statistical issues in the application of cancer outcomes measures. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 362-385.
43. Keeney RL, Raiffa H. Decisions with Multiple Objectives: Preferences and Value Tradeoffs., 2nd ed., Cambridge: Cambridge University Press, 1993.
44. Hays RD, Revicki D, Coyne KS. Application of structural equation modeling to health outcomes research. Eval Health Prof 2005; 28(3): 295-309.
45. Willis GB, Reeve BB, Barofsky I. The use of cognitive interviewing techniques in quality of life and patient-reported outcomes assessment. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 610-622.
46. Darby C. Measuring the patient's perspective on the interpersonal aspects of cancer care. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 290-304.
47. Gustafson DH. Needs assessment in cancer. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 305-328.
48. Dowie J. Decision validity should determine whether a generic or condition-specific HRQOL measure is used in health care decisions. Health Econ 2002; 11: 1-8.
49. Revicki DA. Use of health-related quality of life measures by industry and regulatory agencies in evaluating oncology therapies. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 550-567.
50. Spilker B. The world of outcomes research: Yesterday, today, and tomorrow. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 584-589.
51. Copley-Merriman K, Jackson J, Boyer JG, et al. Industry perspective regarding outcomes research in oncology. In: Lipscomb J, Gotay CC, Snyder C (eds), Outcomes Assessment in Cancer: Measures, Methods, and Applications. Cambridge: Cambridge University Press, 2005: 623-638.